MD, MPH
Assistant Professor, Gastroenterology and Hepatology
UNC-Chapel Hill
Cancer Prevention and Control Research Program
Area of Interest
Hepatocellular carcinoma (HCC), patient-centered treatment decisions in HCC, HCC risk-stratification, HCC screening, hepatic encephalopathy, patient-reported outcomes
Andrew Moon, MD, MPH, has a clinical interest in hepatocellular carcinoma (HCC) and is part of the UNC Multidisciplinary HCC Clinic. Moon has an interest in epidemiology and outcomes research in liver cancer and cirrhosis. His specific research interests include HCC risk stratification and screening, treatment for early stage HCC, patient-centered treatment decisions and addressing post-treatment symptoms through monitoring of patient reported outcomes.
Awards and Honors
- UNC Hospitals & UNC Faculty Physicians Award for Carolina Care Excellence, 2024
- AASLD Liver Cancer Sig Shark Tank Competition, The Liver Meeting, 2023
- Clinical, Translational and Outcomes Research Award, American Association for the Study of Liver Diseases, 2022
- North American International Training Grant, American College of Gastroenterology, 2022
- UNC GI Award for Excellence in Gastrointestinal Research, 2020
- Medicine Resident Excellence in Teaching Award, 2016
- MD with Distinction, 2013
- Alpha Omega Alpha (AOA) Honor Medical Society, 2012
- Gold Humanism Honor Society, 2012
News and Stories
UNC Lineberger researchers advance early-stage liver cancer detection and treatments
Andrew Moon, MD, MPH, and Louise Henderson, PhD, were awarded $400,000 for their new study on the early detection of liver cancer in patients with advanced types of liver disease.
UNC Lineberger provides $1.3 million in developmental research grants
More than $1.3 million in UNC Lineberger developmental research grants were awarded to 13 faculty members and one postdoctoral trainee this spring.
